DEF 14A: Allurion Technologies Seeks Stockholder Approval for Reverse Stock Split and Share Issuance Proposals

Allurion Technologies is asking stockholders to approve a reverse stock split to meet NYSE listing standards and several proposals related to share issuances at its upcoming annual meeting on December 11, 2024.

Summary

• Allurion Technologies is holding its annual meeting of stockholders on December 11, 2024, virtually.
• Stockholders will vote on six proposals, including the election of three Class I Directors, a reverse stock split, and the approval of common stock issuances related to note conversions and private placements.
• The Board recommends voting FOR all proposals.
• A reverse stock split, with a ratio between 1-for-10 and 1-for-25, aims to increase the stock price to comply with NYSE listing requirements.
• Approval is sought for issuing shares upon conversion of notes and preferred stock to comply with NYSE rules, potentially diluting existing stockholders.
• The company is also asking stockholders to ratify the appointment of Deloitte & Touche LLP as the independent auditor for the fiscal year ending December 31, 2024.
• An adjournment proposal is included to allow for further solicitation of votes if needed for Proposals 2, 3, and 4.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While the company is taking steps to address its non-compliance with NYSE listing standards, the need for a reverse stock split and potential dilution of existing shareholders are negative factors.

Positives

• The reverse stock split aims to improve the stock's appeal to a broader range of investors and enhance its perception as an investment security.
• The company has a plan to regain compliance with NYSE listing standards, which includes the reverse stock split.
• The company has engaged Innisfree M&A Incorporated to assist with the solicitation of proxies for the Annual Meeting.

Negatives

• Failure to approve the reverse stock split could lead to delisting from the NYSE.
• The issuance of shares upon conversion of notes and preferred stock will have a dilutive effect on current stockholders.
• The market price of the common stock may decline after the reverse stock split.
• The company may need to raise additional equity capital to regain compliance with the Minimum Market Capitalization Standard.

Risks

• The reverse stock split may not result in an increase in the trading price of the common stock.
• The market price of the common stock will also be based on the performance of the Company and other factors, some of which are unrelated to the number of shares outstanding.
• The liquidity of the common stock may be negatively impacted by the reverse stock split.
• If the company fails to obtain stockholder approval for the Note Shares Issuance and Private Placement Shares Issuance, the company may have to significantly delay, scale back or discontinue the further development and commercialization efforts of one or more of our products, or may be forced to reduce or terminate our operations.

Future Outlook

The company plans to regain compliance with NYSE listing standards, but there is no assurance that it will be successful.

Industry Context

The document does not provide specific details on how this announcement relates to broader industry trends or competitors, but the need to maintain NYSE listing is a common concern for publicly traded companies.

Stakeholder Impact

• Shareholders may experience dilution if the share issuance proposals are approved.
• The reverse stock split could affect the marketability and liquidity of the stock.
• Employees may be affected if the company has to scale back operations due to financial constraints.

Next Steps

• Stockholder vote on the proposals at the Annual Meeting on December 11, 2024.
• Board decision on whether to implement the reverse stock split and the specific ratio.
• Filing of a Certificate of Amendment to the Charter if the reverse stock split is approved and implemented.
• Potential special meetings of stockholders if approval for share issuances is not obtained.

Key Dates

Keywords

reverse stock split, share issuance, proxy statement, annual meeting, NYSE listing, Deloitte & Touche, Allurion Technologies, stockholders, directors, compliance